JPRN-UMIN000008033招募中2 期
A phase II study of Erlotinib plus Pemetrexed for Non Small Cell Lung Cancer with T790M negative previously treated with EGFR-TKI - A phase II study of Erlotinib plus Pemetrexed for Non Small Cell Lung Cancer with T790M negative previously treated with EGFR-TKI
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Presence of active interstitial pneumonia, radiation pneumonia, pneumoconiosis, or drug induced pneumonia 2) Uncontrolled pleural effusion, ascites, or pericardial effusion 3) Previously treated with Pemetrexed 4) Patients with active severe infections 5) Impossible cases with oral administration 6) Patients with uncontrollable complications 7) Pregnancy, breast feeding and suspected pregnancy 8) Active concomitant malignancy 9) Inappropriate patients for this study judged by the physicians
研究者
相似试验
已完成
2 期
A phase II study of Erlotinib plus Pemetrexed for previously treated Non Small Cell Lung Canceron-Small Cell Lung CancerJPRN-UMIN000007397Kochi University, School of Medicine, Department of Hematology and Resporatory Medicine27
已完成
1 期
A Phase I/II study of Pemetrexed plus Erlotinib therapy in Previously Treated Non-Small-Cell Lung Cancer.on-small cell lung cancerJPRN-UMIN000002900Osaka Univ.Hospital Respiratory Medicine40
进行中（未招募）
1 期
A Randomized Phase 2 Study Comparing Erlotinib-Pemetrexed, Pemetrexed alone, and Erlotinib alone, as Second-Line Treatment for Non-Smoker Patients with Locally Advanced or Metastatic Non-Small Cell Lung CancerEUCTR2007-003912-72-GBEli Lilly and Company Limited237
已完成
2 期
A Phase II Study of Erlotinib for previously treated Non-small cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutatioon-small cell lung cancerJPRN-UMIN000002716Central Japan Lung Study Group (CJLSG)29
已完成
2 期
A Phase II Study of Erlotinib for previously treated Non-small cell Lung Cancer Patients without Epidermal Growth Factor Receptor Mutatioon-small cell lung cancerJPRN-UMIN000002692Central Japan Lung Study Group (CJLSG)54